作者: Edward T. Creagan , James N. Ingle , John E. Woods , Douglas J. Pritchard , Nai-Siang Jiang
DOI: 10.1002/1097-0142(19801015)46:8<1785::AID-CNCR2820460815>3.0.CO;2-0
关键词: In patient 、 Incidence (epidemiology) 、 Melanoma 、 Titer 、 Cancer research 、 Internal medicine 、 Medicine 、 Estrogen receptor 、 Endocrinology 、 Oncology
摘要: We detected cytoplasmic estrogen receptors (ER) in only 4 of 34 (12%) patients with malignant melanoma. The titers as assayed by the dextran-coated charcoal method were 3, 4, and 5 fmol/mg, respectively. Our data indicate that incidence melanoma detectable ER is low, which suggests any potential clinical usefulness assay might be limited.